Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 906-627-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Negative results have been obtained with both constituents of the reaction mass.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Comparable to guideline study (OECD 471) with acceptable restrictions (limited documentation, no data on substance purity, prior to GLP, aminoanthracene was used as sole indicator of the efficacy of S9 mix, no E.coli or TA 102 and no TA 100 srains tested)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- - limited description of test substance, no E. coli strain tested, TA 102, and TA 100 strain not tested, 2 Aminoanthracene was sole indicator used to provide information of the efficacy of S9)
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- His Operon
- Species / strain / cell type:
- other: Salmonella typhimurium TA98, TA1535, TA1537, TA1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9), prepared from the livers of rats
- Test concentrations with justification for top dose:
- 500, 1000, 2500, 5000, 7500, 10000, 15000 ug/plate
- Vehicle / solvent:
- ethanol
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: WITH S9: 2 Aminoanthracene (2AA) (TA1538, TA98, TA1535 and 1537). WITHOUT S9: MNNG - H-Methyl-N'-nitro-H-nitrosoguanidine, (TA1535); 2-Nitrofluorene (TA1538 and TA 98); 9-aminoacridine (9AAD)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48h
- Temperature: 37°C
SELECTION AGENT (mutation assays): L-histidine
NUMBER OF DUPLICATES: 2
DETERMINATION OF CYTOTOXICITY
Prior to testing for mutagenicity, the compound was tested for toxicity to the tester strains
- Method: no data
POSITIVE CONTROLS
WITH S9: 2 Aminoanthracene (2AA); 10µg/plate (TA1538 and TA98), 100µg/plate (TA1535 and 1537)
WITHOUT S9: MNNG - H-Methyl-N'-nitro-H-nitrosoguanidine, 2µg/plate (TA1535); 2-Nitrofluorene 25 µg/plate (TA1538 and TA 98); 9-aminoacridine (9AAD) 50 µg/plate (TA1537) - Species / strain:
- other: Salmonella typhimurium TA98, TA1535, TA1537, TA1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
ADDITIONAL INFORMATION ON CYTOTOXICITY:
with S9: >= 7500 µg/plate in TA1537 and >= 10000µg/plate for TA98;
without S9: >= 7500 µg/plate in TA1537 and TA 98 >= 10000µg/plate for TA1538- Remarks on result:
- other: other: Salmonella typhimurium TA98, TA1535, TA1537, TA1538
- Remarks:
- Migrated from field 'Test system'.
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- testing lab.
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- S. typhimurium strains and E. coli
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S-9 mix
- Test concentrations with justification for top dose:
- 10 - 5000 ug/plate (Standard Plate Test); 10 - 1000 ug/plate (PreIncubation Test)
- Vehicle / solvent:
- water
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: with S-9 mix: 2-aminoanthracene; without S-9 mix: N-methyl-N'-nitro-N-nitrosoguanidine, 4-nitro-o-phenylendiamine, 9-aminoacridine and 4-nitroquinoline-N-oxide
- Details on test system and experimental conditions:
- Bacterial test strains were used, both in the standard plate test and in the preincubation test, both in the presence and absence of metabolic activation (+S9, -S9, respectively). DMSO was used as solvent. Three test plates per dose or per control were run in each of the 3 experiments.
- Evaluation criteria:
- The test chemical is considered positive in this assay if the following criteria are met:
• A dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S-9 mix or after adding a metabolizing system.
A test substance is generally considered nonmutagenic in this test if:
• The number of revertants for all tester strains were within the historical negative control range under all experimental conditions in two experiments carried out independently of each other. - Statistics:
- -
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- SOLUBILITY: No precipitation of the test substance was found.
TOXICITY: A bacteriotoxic effect was observed depending on the strain and test conditions from about 100 ug - 2,500 ug/plate onward.
MUTAGENICITY: An increase in the number of his+ or trp+ revertants was not observed in the standard plate test or in the preincubation test either without S-9 mix or after the addition of a metabolizing system. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
According to the results of the present study, the test substance 2-Cyclohexenone pure calc. 100% is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay under the experimental conditions chosen here.
Referenceopen allclose all
Table of Revertant Factors
Strain |
Metabolic activation system |
Duplicates |
revertant factor range |
revertant factor Positive control |
dose dependency |
Cytotoxicity |
Assessment |
TA 1535
|
no |
2 |
0.81-1.4 |
93.8 |
no |
no |
negative |
yes |
2 |
0.6-1.2 |
25.4 |
no |
no |
negative |
|
TA 1537
|
no |
2 |
1.1-1.4 |
36.2 |
|
> = 7500 µg/plate |
negative |
yes |
|
0.8-1.2 |
26 |
no |
> = 7500 µg/plate |
negative |
|
TA 1538
|
no |
2 |
0.7-1.0 |
131.6 |
|
no |
negative |
yes |
|
0.8-1.1 |
93.8 |
no |
no |
negative |
|
TA 98
|
no |
2 |
0.92-1.0 |
108 |
no |
> = 7500 µg/plate |
negative |
yes |
2 |
0.95-1.3 |
90.9 |
no |
> = 10000 µg/plate |
negative |
Assessment using OECD 471 guideline criteria
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
A bacterial reverse gene mutation assay (DuPont 1976, equivalent to OECD guideline 471 with the limitation that no E.coli or TA102 strain was tested) is available. Bacteria strains of S. typhimurium TA 98, TA 1535, TA 1537, TA 1538 were exposed to cyclohexanol (no data on analytical purity) in ethanol at concentrations of 0, 500, 1000, 2500, 5000, 7500, 10000, 15000 μg/plate in the presence and absence of mammalian metabolic activation using the plate incorporation method. Cyclohexanol was tested up to the limit concentration of 5000 μg/plate and beyond. Cytotoxicity was seen at concentrations ≥7500 μg/plate. The positive controls induced the appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for mutagenicity under Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.